Switch View
© PR Newswire
15.10.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Wellcare Enhances Offering of Affordable, Quality Medicare Advantage and Medicare Prescription Drug Plans in 2026
News Preview
Medicare Advantage plans will be available to more than 51 million beneficiaries in 32 states; Prescription Drug Plans will continue to be offered nationwide
New in 2026:
Wellcare to transition Medicare-Medicaid Plans (MMPs) demonstrations to...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: CA82621K1021
Sienna Senior Living Inc
SIA
LISTED
TSX
Sienna Announces October Dividend
News Preview
MARKHAM, Ontario, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “Common Share”) for the month of October 2025, representing $0.936 per Common Share on an annualized basis....
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: US18914F1030
Clover Health Investments Corp
CLOV
LISTED
NASDAQ
Clover Health’s 2026 Medicare Advantage Plans Champion Affordability and Choice
News Preview
The Company Reinforces Market Position, Maintaining Comprehensive PPO Portfolio As Clover Assistant Drives Sustainable Value The Company Reinforces Market Position, Maintaining Comprehensive PPO Portfolio As Clover Assistant Drives Sustainable Value...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
15.10.2025
ISIN: DK0062498333
Novo Nordisk A/S
NOVO B
LISTED
CPH
Novo Nordisk and Omeros announce asset purchase and license agreement for Omeros’ clinical-stage MASP-3 inhibitor zaltenibart (OMS906)
News Preview
Bagsværd, Denmark and Seattle, US, 15 October 2025 – Novo Nordisk and Omeros Corporation (Nasdaq: OMER) today announced that they have entered into a definitive asset purchase and license agreement for the candidate drug zaltenibart (formerly OMS906) in clinical development for rare blood and kidney disorders....
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
15.10.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Wellcare Enhances Offering of Affordable, Quality Medicare Advantage and Medicare Prescription Drug Plans in 2026
News Preview
Medicare Advantage plans will be available to more than 51 million beneficiaries in 32 states; Prescription Drug Plans will continue to be offered nationwide
New in 2026: Wellcare to transition Medicare-Medicaid Plans (MMPs) demonstrations to integrated Dual Eli...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: US00091E1091
Absci Corp
ABSI
LISTED
NASDAQ
Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial
News Preview
Webinar on December 11 to feature leading KOLs in dermatology and hair loss alongside Absci leadership...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: CA3018351047
Extendicare Inc
EXE
LISTED
TSX
Extendicare Announces October 2025 Dividend of C$0.042 per Share
News Preview
MARKHAM, Ontario, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.042 per common share of the Company for the month of October 2025, which is payable on November 17, 2025 to shareholders of record at the close of business on October 31, 2025. This...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: US6024961012
MiMedx Group Inc
MDXG
LISTED
NASDAQ
MIMEDX to Host Third Quarter 2025 Operating and Financial Results Conference Call on October 29
News Preview
MARIETTA, Ga., Oct. 15, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the third quarter ended September 30, 2025 after the market close on Wednesday, October 29, 2025. The MIMEDX senior management team will host a webcast and confe...
Themefolio
Profiler
Peergroup
© BusinessWire
15.10.2025
ISIN: US7743743004
Rockwell Medical Inc
RMTI
LISTED
NASDAQ
Rockwell Medical to Release Third Quarter 2025 Results on Wednesday, November 12, 2025
News Preview
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the third quarter ended September 30, 2025 on Wednesday, Novemb...
Themefolio
Profiler
Peergroup
© BusinessWire
15.10.2025
ISIN: CA05156V1022
Aurinia Pharmaceuticals Inc
AUPH
LISTED
NASDAQ
Aurinia Announces Upcoming Presentations of New Data on LUPKYNIS® at American College of Rheumatology Convergence and American Society of Nephrology Kidney Week 2025
News Preview
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced that five posters will be presented in collaboration with independent investigators highlighting new data on LUPKYNIS® (voclosporin) at the American College of Rheumatology (ACR) Convergence 2025, taking place in Chicago, IL, October 24–29, and the American Society of Nephrology (ASN) Kid...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: US85916J4094
Stereotaxis Inc
STXS
LISTED
XASE
Stereotaxis Announces EU Launch and 510(k) Submission for Synchrony System to Modernize Interventional Cath Labs
News Preview
ST. LOUIS, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it obtained CE Mark in Europe and submitted a 510(k) application to the FDA in the US for the Synchrony™ system....
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: US7599161095
Repligen Corp
RGEN
LISTED
NASDAQ
Repligen to Report Third Quarter 2025 Financial Results
News Preview
Webcast and Conference Call to Be Held Tuesday, October 28, 2025, at 8:30 a.m. ET Webcast and Conference Call to Be Held Tuesday, October 28, 2025, at 8:30 a.m. ET...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
15.10.2025
ISIN: CA01559R1038
Algernon Pharmaceuticals Inc.
AGN
LISTED
CSE
Algernon Pharmaceuticals Completes Name Change to Algernon Health
News Preview
VANCOUVER, British Columbia, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company announces that it has completed its previously announced name change to Algernon Health Inc. The Company’s common shares will begin trading under the...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: US34965KAA51
Fortrea Holdings Inc
FTRE
LISTED
NASDAQ
Fortrea Announces Date for Third Quarter 2025 Financial Results and Conference Call
News Preview
DURHAM, N.C., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its third quarter 2025 financial results before the market opens on Wednesday, November 5, 2025. Fortrea will host a conference call at 8:00 am ET that day to review it...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: US75886F1075
Regeneron Pharmaceuticals Inc
REGN
LISTED
NASDAQ
Regeneron Showcases Advances Across Oncology Portfolio and Pipeline at ESMO, Highlighting Novel and Patient-Focused Approach for Difficult-to-Treat Cancers
News Preview
New safety and pharmacokinetic data from Phase 3 C-POST trial provide insights on an every 6-week dosing regimen of adjuvant Libtayo® (cemiplimab) in high-risk cutaneous squamous cell carcinoma New safety and pharmacokinetic data from Phase 3 C-POST trial provide insights on an every 6-week dosing regimen of adjuvant Libtayo® (cemiplimab) in high-r...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: US4923271013
Keros Therapeutics Inc
KROS
LISTED
NASDAQ
Keros Therapeutics Announces Plan for Return of $375 Million in Excess Capital
News Preview
Agrees to Repurchase of All Shares Held By ADAR1 Capital Management and Pontifax Venture Capital...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: FR0000120578
Sanofi SA
SAN
LISTED
EURONEXT
Communiqué de presse : Sanofi fait de Montpellier le coeur mondial de la recherche translationnelle sur les maladies auto-immunes
News Preview
Sanofi fait de Montpellier le coeur mondial de la recherche translationnelle sur les maladies auto-immunes...
Themefolio
Profiler
Peergroup
© BusinessWire
15.10.2025
ISIN: US3755581036
Gilead Sciences Inc
GILD
LISTED
NASDAQ
Gilead Presents New HIV Research Data at EACS 2025 – Driving Scientific Innovation in Treatment and Prevention
News Preview
Gilead Sciences, Inc. (Nasdaq: GILD) today announced its upcoming participation in the 20th European AIDS Conference (EACS) to be held in Paris, France from October 15-18. As the leader in HIV innovation, Gilead will provide an update on its strategic initiatives, key collaborations, and share new scientific data from its HIV research and developm...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
MOH Investors Have Opportunity to Lead Molina Healthcare, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Oct. 15, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Molina Healthcare, Inc. ("Molina" or "the Company") (NYSE: MOH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
Molina Healthcare, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MOH
News Preview
LOS ANGELES, Oct. 15, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Molina Healthcare, Inc. ("Molina " or "the Company") (NYSE: MOH ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securiti...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
15.10.2025
ISIN: CA00143Y1034
AI-ML Innovations Inc.
AIML
LISTED
CSE
AIML Subsidiary NeuralCloud Solutions and Heartdent Center Ltd. Launch Pilot Project to Advance Cardiac Care in Jamaica
News Preview
Pilot Study to Lay the Groundwork for Expansion Across JamaicaGoal of the Collaboration is to Demonstrate the Ability to Deliver Affordable, Accurate, and Scalable Holter Diagnostics with CardioYield™ TORONTO, ON, AB / ACCESS Newswire / October 15, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AI...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Nutex Health (NUTX) Faces Investor Lawsuit Over Alleged Revenue Inflation Scheme-- Hagens Berman
News Preview
SAN FRANCISCO, Oct. 14, 2025 /PRNewswire/ -- Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of micro-hospitals and healthcare facilities, is under legal scrutiny following a class-action lawsuit that accuses the company of orchestrating a deceptive billing strategy to artificially boost its financia...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: US2358511028
Danaher Corp
DHR
LISTED
NYSE
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR
News Preview
NEW YORK, Oct. 14, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher Corporation (NYSE: DHR)....
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: US04635X1028
Astria Therapeutics Inc
ATXS
LISTED
NASDAQ
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Astria Therapeutics, Inc. (NASDAQ: ATXS)
News Preview
NEW YORK, Oct. 14, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquarte...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: US30233G2093
EyePoint Pharmaceuticals Inc
EYPT
LISTED
NASDAQ
EyePoint Announces Pricing of Public Offering
News Preview
WATERTOWN, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced the pricing of an underwritten public offering of 11,000,000 shares of its common stock at...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: JP3942400007
Astellas Pharma Inc
45030
LISTED
XJPX
Astellas to Present First Real-World VEOZAH™ (fezolinetant) Data at 2025 Annual Meeting of The Menopause Society
News Preview
TOKYO, Oct. 14, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that VEOZAH™ (fezolinetant), its first-in-class, targeted, non-hormonal treatment for moderate to severe vasomotor symptoms (VMS) due to menopause, will be featured in six Astellas-s...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: US98986M1036
Zynex Inc
ZYXI
LISTED
NASDAQ
Zynex Announces Appointment of Bret Wise to Board of Directors as Audit Committee Chair
News Preview
ENGLEWOOD, Colo., Oct. 14, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the appointment of Bret Wise to its Board of Di...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: AILIASX02567
BrightSpring Health Services Inc
BTSG
LISTED
NASDAQ
BrightSpring Health Services Set to Join S&P SmallCap 600
News Preview
NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, October 20. S&P 500 constituent Huntington Bancshares Inc. (NASD: HBAN) is acquiring Veritex H...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
Molina Healthcare, Inc. (MOH) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
BENSALEM, Pa., Oct. 14, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Molina Healthcare, Inc. ("Molina" or the "Company") (NYSE: MOH).
IF YOU ARE...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: US9467841055
Waystar Holding Corp.
WAY
LISTED
NASDAQ
Waystar to Announce Third Quarter 2025 Financial Results on October 29, 2025
News Preview
LEHI, Utah and LOUISVILLE, Ky., Oct. 14, 2025 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, announced today that it will report financial results for the third quarter ended September 30, 2025, after market close on Wednesday, October 29, 2025. The company...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Nutex Health Inc. (NUTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
BENSALEM, Pa., Oct. 14, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX).
IF YOU ARE AN...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: US4523271090
Illumina Inc
ILMN
LISTED
NASDAQ
Illumina to Announce Third Quarter 2025 Financial Results on Thursday, October 30, 2025
News Preview
SAN DIEGO, Oct. 14, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today that it will issue results for the third quarter 2025 following the close of market on Thursday, October 30, 2025.
On the same day, at 1:30 pm Pacific Time (4:30 pm Eastern Time) Jacob Thaysen, PhD, Chief Execu...
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
ISIN: CA60255C8850
Mind Medicine (MindMed) Inc
MNMD
LISTED
NASDAQ
MindMed Announces New Employee Inducement Grant
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the issuance of inducement grants to one newly hired non-executive employee consisting of an option to purchase 28,000 common shares of the Co...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
CYTK Investors Have Opportunity to Lead Cytokinetics, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 14, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Cytokinetics, Inc. (NASDAQ:...
Themefolio
Profiler
Peergroup
© Newsfile
14.10.2025
ISIN: CA0909741062
BioNxt Solutions Inc.
BNXT
LISTED
CSE
CSE Bulletin: MOC Eligibility Update
News Preview
Toronto, Ontario--(Newsfile Corp. - October 14, 2025) - The following CSE-Listed symbol will become MOC Eligible as detailed below. Symbol Company Name Effective Date BNXT...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: US3795772082
Globus Medical Inc
GMED
LISTED
NYSE
Globus Medical Launches ANTHEM™ Elbow Fracture System: A Comprehensive Plating Portfolio for Complex Elbow Trauma
News Preview
AUDUBON, Pa., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, has announced the launch of the ANTHEM™ Elbow Fracture System, a fully comprehensive plating portfolio designed to address a wide spectrum of elbow fractures....
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: US30233G2093
EyePoint Pharmaceuticals Inc
EYPT
LISTED
NASDAQ
EyePoint Announces Proposed Public Offering of Common Stock
News Preview
WATERTOWN, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that it has commenced an underwritten public offering of $150 million of shares of its comm...
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
ISIN: US8523123052
STAAR Surgical Co
STAA
LISTED
NASDAQ
Broadwood Partners Comments on STAAR Surgical’s Late and Troubling Disclosure in Deeply Flawed Sale Process to Alcon
News Preview
Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”) today commented on the recent Current Report on Form 8-K filed by STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) with the U.S. Securities and Exchange Commission (“SEC”) of a “supplement” to the Company’s definitive proxy statement, filed on September 16, 2025, in...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: US05479K1060
Elutia Inc
AZYO
LISTED
NASDAQ
Elutia to Present at the LD Micro Main Event XIX Conference on Tuesday, October 21
News Preview
GAITHERSBURG, Md., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix technologies, today announced that Dr. Randy Mills, President and Chief Executive Officer, will present at the LD Micro Main Event XIX Conference in San Diego on Tuesday, October 21, 2025, at 1:00 p.m. PT (4:00 p.m. ET)....
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: US30233G2093
EyePoint Pharmaceuticals Inc
EYPT
LISTED
NASDAQ
EyePoint Announces Pivotal Phase 3 Program Initiation for DURAVYU™ in Diabetic Macular Edema
News Preview
– DURAVYU now in Phase 3 for the two largest, multi-billion-dollar retinal disease markets, wet AMD and DME with first patient dosing in pivotal Phase 3 DME trials anticipated in Q1 2026 –...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: US00973Y1082
Akero Therapeutics Inc
AKRO
LISTED
NASDAQ
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates EA, HSII, AKRO on Behalf of Shareholders
News Preview
NEW YORK, Oct. 14, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:...
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
ISIN: US98401F1057
Xencor Inc
XNCR
LISTED
NASDAQ
Xencor Announces Presentation of Initial Phase 1 Dose-Escalation Results of XmAb819 in Clear Cell Renal Cell Carcinoma at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
News Preview
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today announced the upcoming presentation of initial results from the ongoing Phase 1 dose-escalation study of XmAb819, a bispecific ENPP3 x CD3 T-cell engaging bispecific antibody, in patient...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: NL0011606264
Merus N.V.
MRUS
LISTED
NASDAQ
Op de AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics kondigt Merus de publicatie aan van het abstract over petosemtamab in gemetastaseerde colorectale kanker
News Preview
- In combinatie met FOLFOX/FOLFIRI (1L en 2L mCRC) en als monotherapie (3L+ mCRC) toont petosemtamab werkzaamheid tegen tumoren en een beheerbaar veiligheidsprofiel aan...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MoonLake Immunotherapeutics (MLTX) Faces Investor Scrutiny After Reporting Disappointing Phase 3 Trial Data For Lead Drug Candidate -- Hagens Berman
News Preview
SAN FRANCISCO, Oct. 14, 2025 /PRNewswire/ -- Investors in MoonLake Immunotherapeutics (NASDAQ: MLTX) saw the price of their shares crater $55.75, or about 90%, after the company announced disastrous VELA-2 trial results for sonelokimab, its highly anticipated treatment for patients with skin disease (hidradenitis...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
ATYR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that aTyr Pharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
NEW YORK, Oct. 14, 2025 /PRNewswire/ -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against aTyr Pharma, Inc. ("aTyr" or "the Company") (NASDAQ: ATYR) and certain of its officers....
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: US04635X1028
Astria Therapeutics Inc
ATXS
LISTED
NASDAQ
Shareholder Alert: The Ademi Firm investigates whether Astria Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders
News Preview
MILWAUKEE, Oct. 14, 2025 /PRNewswire/ -- The Ademi Firm is investigating Astria (NASDAQ: ATXS) for possible breaches of fiduciary duty and other violations of law in its transaction with BioCryst....
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: FR0000120578
Sanofi SA
SAN
LISTED
EURONEXT
Sanofi: Information concerning the total number of voting rights and shares - September 2025
News Preview
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority)...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LFMD 13-DAY DEADLINE ALERT: Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman
News Preview
LFMD Investors with Losses Encouraged to Contact the Firm Before Oct. 27th Deadline
SAN FRANCISCO, Oct. 14, 2025 /PRNewswire/ -- A new federal securities fraud class action lawsuit has been filed against LifeMD (NASDAQ: LFMD), alleging that the telehealth company and its executives provided invest...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: US0367521038
Elevance Health Inc
ANTM
LISTED
NYSE
NYSE: ELV Lawsuit Update: Investors in Elevance Health, Inc. (NYSE: ELV) shares should contact the Shareholders Foundation in connection with pending Lawsuit
News Preview
SAN DIEGO, Oct. 14, 2025 /PRNewswire/ -- The Shareholders Foundation, Inc. announces that an update in the lawsuit that is currently pending for certain investors in Elevance Health, Inc. (NYSE: ELV) shares....
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Veeva AI Agents to Be Released Across All Veeva Applications
News Preview
Deep, industry-specific agents planned for availability starting this December
PLEASANTON, Calif., Oct. 14, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva AI Agents are planned for availability starting December 2025 for commercial and acr...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Veeva AI Agents to Be Released Across All Veeva Applications
News Preview
Deep, industry-specific agents planned for availability starting this December
PLEASANTON, Calif., Oct. 14, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva AI Agents are planned for availability starting December 2025 for commercial and acr...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: AU0000165375
Clarity Pharmaceuticals Ltd
CU6
LISTED
ASX
Co-PSMA trial achieves primary endpoint
News Preview
SYDNEY, Oct. 14, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce that the Co-PSMA (NCT06907641)[1] Inve...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: KR7328130000
Lunit Inc.
328130
LISTED
KOE
Lunit AI Predicts Immunotherapy Outcome in Colorectal, Kidney, and Lung Cancer at ESMO 2025
News Preview
AI-powered histopathology demonstrates predictive value for immunotherapy outcomes in pMMR mCRC, advanced ccRCC, and NSCLC with data featured in both oral and poster presentations
SEOUL, South Korea, Oct. 14, 2025 /PRNewsw...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: US01625V1044
Alignment Healthcare Inc
ALHC
LISTED
NASDAQ
Alignment Health Plan and Intermountain Health Launch $0-Premium, 5-star Medicare Advantage Plan for Nevada Seniors
News Preview
New co-branded HMO expands access to high-quality, affordable care in Clark County, adding second 5-star plan for Alignment in the state New co-branded HMO expands access to high-quality, affordable care in Clark County, adding second 5-star plan for Alignment in the state...
Themefolio
Profiler
Peergroup
© Newsfile
14.10.2025
ISIN: CA75671E1097
Red Light Holland Corp.
TRIP
LISTED
CSE
Red Light Holland Secures Second United States Controlled Substances Import Permit for the Company's Psilocybin Through FDA-Compliant, DEA-Registered Partner Irvine Labs
News Preview
Red Light Holland granted Second DEA Import Permit through Irvine Labs for expanded psilocybin research programThis United States Controlled Substances Permit, authorizes a significantly larger shipment of psilocybin truffles, from Red Light Holland's Netherlands facility, for continued R&DToronto, Ontario--(Newsfile Corp. - October 14, 2025) -...
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
ISIN: US74051N1028
Premier Inc
PINC
LISTED
NASDAQ
Premier, Inc. to Report Fiscal 2026 First Quarter Results on November 4, 2025
News Preview
Premier, Inc. (NASDAQ: PINC) today announced that it will release financial results for its fiscal 2026 first quarter on Tuesday, November 4, 2025, at approximately 6:30 a.m. ET.
As a result of the company’s pending acquisition by Patient Square Capital, Premier will not host a conference call to discuss its financial results.
About Premier, I...
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
ISIN: US04635X1028
Astria Therapeutics Inc
ATXS
LISTED
NASDAQ
ATXS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Astria Therapeutics, Inc. Is Fair to Shareholders
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Astria Therapeutics, Inc. (NASDAQ: ATXS) to BioCryst Pharmaceuticals, Inc. for $8.55 in cash per share and 0.59 shares of BioCryst common stock per share of Astria is fair to Astria shareholders.
Halper Sadeh encourages Astria shareholders to click here to learn...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
aTyr Pharma, Inc.'s (ATYR) Failed Drug Trial Spurs Securities Lawsuit -- Hagens Berman
News Preview
ATYR Investors with Losses Encouraged to Contact Hagens Berman
SAN FRANCISCO, Oct. 14, 2025 /PRNewswire/ -- A federal class-action lawsuit has been filed against aTyr Pharma, Inc. (NASDAQ: ATYR) following a devastating 83% drop in the biotech company's stock price after its lead drug candidate fai...
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
ISIN: US8636671013
Stryker Corp
SYK
LISTED
NYSE
Stryker to Feature Expanding Trauma Portfolio at the Orthopaedic Trauma Association Annual Meeting 2025
News Preview
Stryker (NYSE:SYK), a global leader in medical technologies, will showcase new additions to its trauma offerings at the Orthopaedic Trauma Association (OTA) Annual Meeting, October 15–18, in Phoenix, Ariz. (booth #601). The company will highlight upcoming expansions to its nailing and plating platforms.
For more than 80 years, Stryker has collab...
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
ISIN: US36266G1076
GE Healthcare Technologies Inc
GEHC
LISTED
NASDAQ
GE HealthCare launches CareIntellect for Perinatal, a cloud-first application to optimize care delivery and help send families home healthy
News Preview
GE HealthCare (Nasdaq: GEHC) today announced the launch of CareIntellect™ for Perinatal2, a cloud-first Software-as-a-Service (SaaS) application designed to deliver clear, actionable insights that help clinicians improve maternal and fetal care.3 CareIntellect for Perinatal supports clinicians by integrating information from disparate clinical sou...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
